1654:TSE:TSE-Daiwa FTSE Blossom Japan (JPY)

ETF | Others |

Last Closing

USD 2245.5

Change

0.00 (0.00)%

Market Cap

USD 1.92B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
1306:TSE Nomura TOPIX Listed

+18.00 (+0.64%)

USD 23,611.00B
1308:TSE Nikko TOPIX Listed

+21.00 (+0.76%)

USD 11,091.37B
1321:TSE Nomura Nikkei 225 Listed

+310.00 (+0.79%)

USD 11,082.14B
1305:TSE Daiwa TOPIX Listed

+22.00 (+0.77%)

USD 10,799.81B
1330:TSE Nikko Nikkei 225 Listed

+280.00 (+0.71%)

USD 5,423.56B
1320:TSE Daiwa Nikkei 225 Listed

+310.00 (+0.79%)

USD 5,181.88B
1348:TSE MAXIS TOPIX

+21.50 (+0.77%)

USD 3,383.69B
1346:TSE MAXIS Nikkei 225

+310.00 (+0.79%)

USD 2,731.89B
1475:TSE iShares Core TOPIX ETF

+22.00 (+0.80%)

USD 1,877.98B
1591:TSE NEXT FUNDS JPX-Nikkei Index 40..

+80.00 (+0.33%)

USD 1,666.73B

ETFs Containing 1654:TSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.98% 82% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.98% 82% B 79% B-
Trailing 12 Months  
Capital Gain 43.30% 74% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.30% 74% C 68% D+
Trailing 5 Years  
Capital Gain 89.33% 71% C- 81% B-
Dividend Return 1.42% 44% F 5% F
Total Return 90.76% 71% C- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 11.78% 63% D 68% D+
Dividend Return 11.88% 63% D 64% D
Total Return 0.10% 41% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 13.92% 68% D+ 87% B+
Risk Adjusted Return 85.34% 85% B 94% A
Market Capitalization 1.92B 23% F 4% F

Annual Financials (JPY)

Quarterly Financials (JPY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.